What is the recommended dose of albuterol (beta2-adrenergic agonist) solution for pediatric patients?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 22, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Albuterol Solution Dosing for Pediatric Patients

For pediatric patients, the recommended dose of albuterol nebulizer solution is 0.15 mg/kg (minimum dose 2.5 mg) every 20 minutes for 3 doses, then 0.15-0.3 mg/kg up to 10 mg every 1-4 hours as needed, or 0.5 mg/kg/hour by continuous nebulization. 1

Weight-Based Dosing Algorithm

For Intermittent Nebulization:

  • Children <15 kg: Use albuterol inhalation solution 0.5% instead of 0.083% 2
  • Children ≥15 kg: 2.5 mg (one 3 mL vial of 0.083% solution) administered 3-4 times daily 2
  • All children: Initial treatment for acute exacerbations: 0.15 mg/kg (minimum 2.5 mg) every 20 minutes for 3 doses 1, 3
  • Maintenance dosing: 0.15-0.3 mg/kg up to 10 mg every 1-4 hours as needed 1

For Continuous Nebulization:

  • All children: 0.5 mg/kg/hour continuous nebulization 1
  • No optimal weight-based dose has been definitively established, with studies using doses ranging from 0.07-3.2 mg/kg/hour 4

Administration Methods

Nebulizer Solution:

  • For optimal delivery, dilute aerosols to minimum of 3 mL at gas flow of 6-8 L/min 1
  • Use large volume nebulizers for continuous administration 1
  • May mix with ipratropium bromide nebulizer solution for severe exacerbations 1, 3

Metered-Dose Inhaler (MDI):

  • Children: 4-8 puffs every 20 minutes for 3 doses, then every 1-4 hours as needed 1, 3
  • Always use with valved holding chamber/spacer for children 1, 3
  • Allow 6-8 breaths per actuation when using a spacer 3

Special Considerations

Levalbuterol Alternative:

  • Levalbuterol (R-albuterol) can be administered at half the mg dose of albuterol with comparable efficacy and safety 1, 5
  • Recommended dose: 0.075 mg/kg (minimum dose 1.25 mg) every 20 minutes for 3 doses, then 0.075-0.15 mg/kg up to 5 mg every 1-4 hours as needed 1
  • For children with mild to moderate persistent asthma, 0.31 mg is an effective starting dose 5

Monitoring and Safety

Side Effects to Monitor:

  • Tachycardia (dose-related) 3, 6
  • Tremors (dose-related) 3, 6
  • Hypokalemia (serum potassium <3.0 mEq/L) - relatively uncommon at standard doses 3, 6
  • Cardiac arrhythmias - rare but possible 3, 6

Important Caveats:

  • Higher doses of albuterol (beyond standard recommendations) have not been shown to improve outcomes in terms of hospital length of stay or admission rates 4, 7
  • Lower doses of albuterol via MDI (6-12 puffs) are as effective as higher doses (9-18 puffs) for acute asthma exacerbations 7
  • If a previously effective dosage regimen fails to provide usual relief, this often indicates worsening asthma requiring reassessment of therapy 2
  • For very young infants with bronchopulmonary dysplasia, even lower doses (1.25 mg) may be appropriate with careful heart monitoring 8

Treatment Duration

  • Continue albuterol as medically indicated to control recurring bouts of bronchospasm 2
  • For acute exacerbations, treatment is typically continued until symptoms improve, with follow-up in 2-6 weeks to assess response 3

Remember that the goal of albuterol treatment is to minimize symptoms to ≤2 days/week with minimal or no exacerbations, no activity limitations, and maintenance of near-normal pulmonary function 3.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Asthma Management in Children

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Association of various weight-based doses of continuous albuterol on hospital length of stay.

The Journal of asthma : official journal of the Association for the Care of Asthma, 2021

Research

Effect of high-dose continuous albuterol nebulization on clinical variables in children with status asthmaticus.

Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies, 2015

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.